Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Benralizumab on Mannitol Challenge in Severe Eosinophilic Asthma
2019-003763-22Phase 3Unknown
- Sponsor
- University of Dundee
- Start
- Feb 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, single-arm trial of benralizumab in eosinophilic asthma (EA) and asthma, sponsored by University of Dundee. Primary endpoint: Change in mannitol PD10. Status: unknown.
02
Drugs
benralizumab
03
Conditions
eosinophilic asthma (EA)asthma
Beyond the preview
Go deeper on 2019-003763-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-003763-22.